The invention relates to a duck short
beak dwarf syndrome
gene engineering subunit inactivated vaccine and a preparation method thereof. Aiming at a
variant strain, the VP2
gene of the SBDS-GPV JS01 strain is subjected to
codon optimization and is cloned to a baculovirus vector, so that a
recombinant baculovirus rBac-JS01VP2 strain is successfully constructed;
insect cell full suspension (or spinner
bottle) culture is adopted, the technology is mature, and production transformation and step-by-step amplification culture are facilitated; compared with traditional
duck embryo or
duck embryo fibroblast culture, the
virus titer is high, the quality is stable, the production period is short, and the cost is low; compared with an
antibody product, the protection rate is high, the
duration time of a
maternal antibody is long, only female ducks are immunized, and labor and cost are saved; serum or egg source miscellaneous
protein does not exist, and the
side reaction is extremely low; the expressed VP2
protein can be assembled into
virus-like particles (VLPs), and the
immunogenicity is good; the expression quantity is high (when the
virus titer is 8.0 Log10TCID50 / ml, the VP2
protein expression quantity reaches 50-100 mg / L), the
antibody level is high, and the lasting time is long; the
shelf life of the product is 18 months, and the immune period is 6 months; and the ELISA
antibody detection method is used for screening susceptible ducks and evaluating
efficacy.